Literature DB >> 16196424

Synthesis and biological activity of new iodoacetamide derivatives on mutants of squalene-hopene cyclase.

Maurizio Ceruti1, Gianni Balliano, Flavio Rocco, Alexander Lenhart, Georg E Schulz, Francesco Castelli, Paola Milla.   

Abstract

New iodoacetamide derivatives, containing a dodecyl or a squalenyl moiety, were synthesized. The effect of these new thiol-reacting molecules was studied on two mutants of Alicyclobacillus acidocaldarius squalene-hopene cyclase constructed especially for this purpose. In the quintuple mutant, all five cysteine residues of the enzyme are substituted with serine; in the sextuple mutant, this quintuple substitution is accompanied by the substitution of aspartate D376, located at the enzyme's active site, with a cysteine. N-Dodecyliodoacetamide had little activity toward either mutant, whereas N-squalenyliodoacetamide showed a stronger effect on the sextuple than on the quintuple mutant, as expected.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16196424     DOI: 10.1007/s11745-005-1436-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  24 in total

1.  2,3,18,19-Dioxidosqualene Stereoisomers: Characterization and Activity as Inhibitors of Purified Pig Liver 2,3-Oxidosqualene-Lanosterol Cyclase.

Authors:  José-Luis Abad; Marisa Guardiola; Josefina Casas; Francisco Sánchez-Baeza; Angel Messeguer
Journal:  J Org Chem       Date:  1996-10-18       Impact factor: 4.354

2.  Enzyme Mechanisms for Polycyclic Triterpene Formation.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-08-18       Impact factor: 15.336

3.  Chemical modification of the Ca(2+)-ATPase of rabbit skeletal muscle sarcoplasmic reticulum: identification of sites labeled with aryl isothiocyanates and thiol-directed conformational probes.

Authors:  A Wawrzynów; J H Collins
Journal:  Biochim Biophys Acta       Date:  1993-11-10

4.  Rationally designed inhibitors as tools for comparing the mechanism of squalene-hopene cyclase with oxidosqualene cyclase.

Authors:  F Viola; M Ceruti; L Cattel; P Milla; K Poralla; G Balliano
Journal:  Lipids       Date:  2000-03       Impact factor: 1.880

5.  Site-directed mutagenesis of putative active-site residues in squalene-hopene cyclase.

Authors:  C Feil; R Süssmuth; G Jung; K Poralla
Journal:  Eur J Biochem       Date:  1996-11-15

6.  Affinity labeling of vertebrate oxidosqualene cyclases with a tritiated suicide substrate.

Authors:  I Abe; M Bai; X Y Xiao; G D Prestwich
Journal:  Biochem Biophys Res Commun       Date:  1992-08-31       Impact factor: 3.575

7.  The squalene-2,3-epoxide cyclase as a model for the development of new drugs.

Authors:  L Cattel; M Ceruti; F Viola; L Delprino; G Balliano; A Duriatti; P Bouvier-Navé
Journal:  Lipids       Date:  1986-01       Impact factor: 1.880

8.  Inhibition of mammalian squalene synthetase activity by zaragozic acid A is a result of competitive inhibition followed by mechanism-based irreversible inactivation.

Authors:  S Lindsey; H J Harwood
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

9.  The effects of the hypocholesteremic compound 3 beta-(beta-dimethylaminoethoxy)-androst-5-en-17-one on the sterol and steryl ester composition of Saccharomyces cerevisiae.

Authors:  R B Field; C E Holmlund; N F Whittaker
Journal:  Lipids       Date:  1979-08       Impact factor: 1.880

10.  Inhibition of 2,3-oxidosqualene cyclases.

Authors:  M Taton; P Benveniste; A Rahier; W S Johnson; H T Liu; A R Sudhakar
Journal:  Biochemistry       Date:  1992-09-01       Impact factor: 3.162

View more
  2 in total

1.  Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases.

Authors:  Donato Cosco; Flavio Rocco; Maurizio Ceruti; Margherita Vono; Massimo Fresta; Donatella Paolino
Journal:  Int J Nanomedicine       Date:  2012-05-23

2.  5-Aminolevulinic Acid-Squalene Nanoassemblies for Tumor Photodetection and Therapy: In Vitro Studies.

Authors:  Andrej Babič; V Herceg; E Bastien; H-P Lassalle; L Bezdetnaya; Norbert Lange
Journal:  Nanoscale Res Lett       Date:  2018-01-11       Impact factor: 4.703

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.